<?xml version="1.0" encoding="utf-8" standalone="no"?>
<billStatus>
  <version>3.0.0</version>
  <bill>
    <number>639</number>
    <updateDate>2023-04-24T20:39:41Z</updateDate>
    <updateDateIncludingText>2023-04-24T20:39:41Z</updateDateIncludingText>
    <originChamber>House</originChamber>
    <type>HR</type>
    <introducedDate>2015-02-02</introducedDate>
    <congress>114</congress>
    <constitutionalAuthorityStatementText><![CDATA[<pre>[Congressional Record Volume 161, Number 17 (Monday, February 2, 2015)]From the Congressional Record Online through the Government Publishing Office [<a href='http://www.gpo.gov'>www.gpo.gov</a>]By Mr. PITTS:H.R. 639.Congress has the power to enact this legislation pursuantto the following:Article I, Section 8, Clause 3, which states that Congressshall have the power ``to regulate commerce with foreignnations, and among the several states . . .''[Page H704]</pre>]]></constitutionalAuthorityStatementText>
    <committees>
      <item>
        <systemCode>sshr00</systemCode>
        <name>Health, Education, Labor, and Pensions Committee</name>
        <chamber>Senate</chamber>
        <type>Standing</type>
        <activities>
          <item>
            <name>Discharged from</name>
            <date>2015-10-26T22:05:46Z</date>
          </item>
          <item>
            <name>Referred to</name>
            <date>2015-03-17T19:13:45Z</date>
          </item>
        </activities>
      </item>
      <item>
        <systemCode>hsju00</systemCode>
        <name>Judiciary Committee</name>
        <chamber>House</chamber>
        <type>Standing</type>
        <subcommittees>
          <item>
            <systemCode>hsju08</systemCode>
            <name>Crime and Federal Government Surveillance Subcommittee</name>
            <activities>
              <item>
                <name>Referred to</name>
                <date>2015-02-03T16:06:25Z</date>
              </item>
            </activities>
          </item>
        </subcommittees>
        <activities>
          <item>
            <name>Discharged from</name>
            <date>2015-03-16T19:00:30Z</date>
          </item>
          <item>
            <name>Referred to</name>
            <date>2015-02-02T17:00:45Z</date>
          </item>
        </activities>
      </item>
      <item>
        <systemCode>hsif00</systemCode>
        <name>Energy and Commerce Committee</name>
        <chamber>House</chamber>
        <type>Standing</type>
        <subcommittees>
          <item>
            <systemCode>hsif14</systemCode>
            <name>Health Subcommittee</name>
            <activities>
              <item>
                <name>Referred to</name>
                <date>2015-02-06T18:42:59Z</date>
              </item>
            </activities>
          </item>
        </subcommittees>
        <activities>
          <item>
            <name>Reported by</name>
            <date>2015-03-16T19:00:14Z</date>
          </item>
          <item>
            <name>Referred to</name>
            <date>2015-02-02T17:00:40Z</date>
          </item>
        </activities>
      </item>
    </committees>
    <committeeReports>
      <committeeReport>
        <citation>H. Rept. 114-41</citation>
      </committeeReport>
    </committeeReports>
    <relatedBills>
      <item>
        <title>Improving Regulatory Transparency for New Medical Therapies Act</title>
        <congress>114</congress>
        <number>481</number>
        <type>S</type>
        <latestAction>
          <actionDate>2015-10-01</actionDate>
          <text>Placed on Senate Legislative Calendar under General Orders. Calendar No. 245.</text>
        </latestAction>
        <relationshipDetails>
          <item>
            <type>Related bill</type>
            <identifiedBy>CRS</identifiedBy>
          </item>
        </relationshipDetails>
      </item>
    </relatedBills>
    <actions>
      <item>
        <actionDate>2015-11-25</actionDate>
        <text>Became Public Law No: 114-89.</text>
        <type>President</type>
        <actionCode>E40000</actionCode>
        <sourceSystem>
          <code>2</code>
          <name>House floor actions</name>
        </sourceSystem>
      </item>
      <item>
        <actionDate>2015-11-25</actionDate>
        <text>Became Public Law No: 114-89.</text>
        <type>BecameLaw</type>
        <actionCode>36000</actionCode>
        <sourceSystem>
          <code>9</code>
          <name>Library of Congress</name>
        </sourceSystem>
      </item>
      <item>
        <actionDate>2015-11-25</actionDate>
        <text>Signed by President.</text>
        <type>President</type>
        <actionCode>E30000</actionCode>
        <sourceSystem>
          <code>2</code>
          <name>House floor actions</name>
        </sourceSystem>
      </item>
      <item>
        <actionDate>2015-11-25</actionDate>
        <text>Signed by President.</text>
        <type>BecameLaw</type>
        <actionCode>36000</actionCode>
        <sourceSystem>
          <code>9</code>
          <name>Library of Congress</name>
        </sourceSystem>
      </item>
      <item>
        <actionDate>2015-11-19</actionDate>
        <text>Presented to President.</text>
        <type>Floor</type>
        <actionCode>E20000</actionCode>
        <sourceSystem>
          <code>2</code>
          <name>House floor actions</name>
        </sourceSystem>
      </item>
      <item>
        <actionDate>2015-11-19</actionDate>
        <text>Presented to President.</text>
        <type>President</type>
        <actionCode>28000</actionCode>
        <sourceSystem>
          <code>9</code>
          <name>Library of Congress</name>
        </sourceSystem>
      </item>
      <item>
        <actionDate>2015-11-16</actionDate>
        <actionTime>19:19:56</actionTime>
        <text>Motion to reconsider laid on the table Agreed to without objection.</text>
        <type>ResolvingDifferences</type>
        <actionCode>H41931</actionCode>
        <sourceSystem>
          <code>2</code>
          <name>House floor actions</name>
        </sourceSystem>
      </item>
      <item>
        <actionDate>2015-11-16</actionDate>
        <actionTime>19:19:55</actionTime>
        <text>On motion that the House agree to the Senate amendment Agreed to without objection. (text as House agreed to Senate amendment: CR H8212-8213)</text>
        <type>ResolvingDifferences</type>
        <actionCode>H41610</actionCode>
        <sourceSystem>
          <code>2</code>
          <name>House floor actions</name>
        </sourceSystem>
      </item>
      <item>
        <actionDate>2015-11-16</actionDate>
        <text>Resolving differences -- House actions: On motion that the House agree to the Senate amendment Agreed to without objection.(text as House agreed to Senate amendment: CR H8212-8213)</text>
        <type>NotUsed</type>
        <actionCode>19500</actionCode>
        <sourceSystem>
          <code>9</code>
          <name>Library of Congress</name>
        </sourceSystem>
      </item>
      <item>
        <actionDate>2015-11-16</actionDate>
        <actionTime>19:19:26</actionTime>
        <text>Mr. Griffith asked unanimous consent that the House agree to the Senate amendment. (consideration: CR H8212-8213)</text>
        <type>ResolvingDifferences</type>
        <actionCode>H40110</actionCode>
        <sourceSystem>
          <code>2</code>
          <name>House floor actions</name>
        </sourceSystem>
      </item>
      <item>
        <actionDate>2015-10-27</actionDate>
        <sourceSystem>
          <name>Senate</name>
        </sourceSystem>
        <text>Message on Senate action sent to the House.</text>
        <type>Floor</type>
      </item>
      <item>
        <actionDate>2015-10-26</actionDate>
        <sourceSystem>
          <name>Senate</name>
        </sourceSystem>
        <text>Passed Senate with an amendment by Unanimous Consent.</text>
        <type>Floor</type>
      </item>
      <item>
        <actionDate>2015-10-26</actionDate>
        <text>Passed/agreed to in Senate: Passed Senate with an amendment by Unanimous Consent.</text>
        <type>Floor</type>
        <actionCode>17000</actionCode>
        <sourceSystem>
          <code>9</code>
          <name>Library of Congress</name>
        </sourceSystem>
      </item>
      <item>
        <actionDate>2015-10-26</actionDate>
        <sourceSystem>
          <name>Senate</name>
        </sourceSystem>
        <text>Measure laid before Senate by unanimous consent. (consideration: CR S7495)</text>
        <type>Floor</type>
      </item>
      <item>
        <actionDate>2015-10-26</actionDate>
        <committees>
          <item>
            <systemCode>sshr00</systemCode>
            <name>Health, Education, Labor, and Pensions Committee</name>
          </item>
        </committees>
        <sourceSystem>
          <name>Senate</name>
        </sourceSystem>
        <text>Senate Committee on Health, Education, Labor, and Pensions discharged by Unanimous Consent. (consideration: CR S7495)</text>
        <type>Discharge</type>
      </item>
      <item>
        <actionDate>2015-10-26</actionDate>
        <text>Senate Committee on Health, Education, Labor, and Pensions discharged by Unanimous Consent.(consideration: CR S7495)</text>
        <type>Committee</type>
        <actionCode>14500</actionCode>
        <sourceSystem>
          <code>9</code>
          <name>Library of Congress</name>
        </sourceSystem>
        <committees>
          <item>
            <systemCode>sshr00</systemCode>
            <name>Health, Education, Labor, and Pensions Committee</name>
          </item>
        </committees>
      </item>
      <item>
        <actionDate>2015-03-17</actionDate>
        <committees>
          <item>
            <systemCode>sshr00</systemCode>
            <name>Health, Education, Labor, and Pensions Committee</name>
          </item>
        </committees>
        <sourceSystem>
          <name>Senate</name>
        </sourceSystem>
        <text>Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.</text>
        <type>IntroReferral</type>
      </item>
      <item>
        <actionDate>2015-03-16</actionDate>
        <actionTime>15:39:54</actionTime>
        <text>Motion to reconsider laid on the table Agreed to without objection.</text>
        <type>Floor</type>
        <actionCode>H38310</actionCode>
        <sourceSystem>
          <code>2</code>
          <name>House floor actions</name>
        </sourceSystem>
      </item>
      <item>
        <actionDate>2015-03-16</actionDate>
        <actionTime>15:39:52</actionTime>
        <text>On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H1638-1639)</text>
        <type>Floor</type>
        <actionCode>H37300</actionCode>
        <sourceSystem>
          <code>2</code>
          <name>House floor actions</name>
        </sourceSystem>
      </item>
      <item>
        <actionDate>2015-03-16</actionDate>
        <actionTime>15:39:52</actionTime>
        <text>Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote.(text: CR H1638-1639)</text>
        <type>Floor</type>
        <actionCode>8000</actionCode>
        <sourceSystem>
          <code>9</code>
          <name>Library of Congress</name>
        </sourceSystem>
      </item>
      <item>
        <actionDate>2015-03-16</actionDate>
        <actionTime>15:31:33</actionTime>
        <text>DEBATE - The House proceeded with forty minutes of debate on H.R. 639.</text>
        <type>Floor</type>
        <actionCode>H8D000</actionCode>
        <sourceSystem>
          <code>2</code>
          <name>House floor actions</name>
        </sourceSystem>
      </item>
      <item>
        <actionDate>2015-03-16</actionDate>
        <actionTime>15:31:30</actionTime>
        <text>Considered under suspension of the rules. (consideration: CR H1638-1641)</text>
        <type>Floor</type>
        <actionCode>H30000</actionCode>
        <sourceSystem>
          <code>2</code>
          <name>House floor actions</name>
        </sourceSystem>
      </item>
      <item>
        <actionDate>2015-03-16</actionDate>
        <actionTime>15:31:07</actionTime>
        <text>Mr. Pitts moved to suspend the rules and pass the bill, as amended.</text>
        <type>Floor</type>
        <actionCode>H30300</actionCode>
        <sourceSystem>
          <code>2</code>
          <name>House floor actions</name>
        </sourceSystem>
      </item>
      <item>
        <actionDate>2015-03-16</actionDate>
        <text>Placed on the Union Calendar, Calendar No. 26.</text>
        <type>Calendars</type>
        <actionCode>H12410</actionCode>
        <sourceSystem>
          <code>2</code>
          <name>House floor actions</name>
        </sourceSystem>
        <calendarNumber>
          <calendar>U00026</calendar>
        </calendarNumber>
      </item>
      <item>
        <actionDate>2015-03-16</actionDate>
        <text>Committee on the Judiciary discharged.</text>
        <type>Discharge</type>
        <actionCode>H12300</actionCode>
        <sourceSystem>
          <code>2</code>
          <name>House floor actions</name>
        </sourceSystem>
        <committees>
          <item>
            <systemCode>hsju00</systemCode>
            <name>Judiciary Committee</name>
          </item>
        </committees>
      </item>
      <item>
        <actionDate>2015-03-16</actionDate>
        <text>Committee on the Judiciary discharged.</text>
        <type>Committee</type>
        <actionCode>5500</actionCode>
        <sourceSystem>
          <code>9</code>
          <name>Library of Congress</name>
        </sourceSystem>
        <committees>
          <item>
            <systemCode>hsju00</systemCode>
            <name>Judiciary Committee</name>
          </item>
        </committees>
      </item>
      <item>
        <actionDate>2015-03-16</actionDate>
        <text>Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 114-41, Part I.</text>
        <type>Committee</type>
        <actionCode>H12200</actionCode>
        <sourceSystem>
          <code>2</code>
          <name>House floor actions</name>
        </sourceSystem>
        <committees>
          <item>
            <systemCode>hsif00</systemCode>
            <name>Energy and Commerce Committee</name>
          </item>
        </committees>
      </item>
      <item>
        <actionDate>2015-03-16</actionDate>
        <text>Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 114-41, Part I.</text>
        <type>Committee</type>
        <actionCode>5000</actionCode>
        <sourceSystem>
          <code>9</code>
          <name>Library of Congress</name>
        </sourceSystem>
        <committees>
          <item>
            <systemCode>hsif00</systemCode>
            <name>Energy and Commerce Committee</name>
          </item>
        </committees>
      </item>
      <item>
        <actionDate>2015-02-06</actionDate>
        <committees>
          <item>
            <systemCode>hsif14</systemCode>
            <name>Health Subcommittee</name>
          </item>
        </committees>
        <sourceSystem>
          <code>1</code>
          <name>House committee actions</name>
        </sourceSystem>
        <text>Referred to the Subcommittee on Health.</text>
        <type>Committee</type>
      </item>
      <item>
        <actionDate>2015-02-03</actionDate>
        <committees>
          <item>
            <systemCode>hsju08</systemCode>
            <name>Crime and Federal Government Surveillance Subcommittee</name>
          </item>
        </committees>
        <sourceSystem>
          <code>1</code>
          <name>House committee actions</name>
        </sourceSystem>
        <text>Referred to the Subcommittee on Crime, Terrorism, Homeland Security, and Investigations.</text>
        <type>Committee</type>
      </item>
      <item>
        <actionDate>2015-02-02</actionDate>
        <text>Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.</text>
        <type>IntroReferral</type>
        <actionCode>H11100</actionCode>
        <sourceSystem>
          <code>2</code>
          <name>House floor actions</name>
        </sourceSystem>
        <committees>
          <item>
            <systemCode>hsju00</systemCode>
            <name>Judiciary Committee</name>
          </item>
        </committees>
      </item>
      <item>
        <actionDate>2015-02-02</actionDate>
        <text>Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.</text>
        <type>IntroReferral</type>
        <actionCode>H11100</actionCode>
        <sourceSystem>
          <code>2</code>
          <name>House floor actions</name>
        </sourceSystem>
        <committees>
          <item>
            <systemCode>hsif00</systemCode>
            <name>Energy and Commerce Committee</name>
          </item>
        </committees>
      </item>
      <item>
        <actionDate>2015-02-02</actionDate>
        <text>Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.</text>
        <type>IntroReferral</type>
        <actionCode>H11100-A</actionCode>
        <sourceSystem>
          <code>9</code>
          <name>Library of Congress</name>
        </sourceSystem>
      </item>
      <item>
        <actionDate>2015-02-02</actionDate>
        <text>Introduced in House</text>
        <type>IntroReferral</type>
        <actionCode>Intro-H</actionCode>
        <sourceSystem>
          <code>9</code>
          <name>Library of Congress</name>
        </sourceSystem>
      </item>
      <item>
        <actionDate>2015-02-02</actionDate>
        <text>Introduced in House</text>
        <type>IntroReferral</type>
        <actionCode>1000</actionCode>
        <sourceSystem>
          <code>9</code>
          <name>Library of Congress</name>
        </sourceSystem>
      </item>
    </actions>
    <sponsors>
      <item>
        <bioguideId>P000373</bioguideId>
        <fullName>Rep. Pitts, Joseph R. [R-PA-16]</fullName>
        <firstName>JOSEPH</firstName>
        <lastName>PITTS</lastName>
        <party>R</party>
        <state>PA</state>
        <middleName>R.</middleName>
        <district>16</district>
        <isByRequest>N</isByRequest>
      </item>
    </sponsors>
    <cosponsors>
      <item>
        <bioguideId>P000034</bioguideId>
        <fullName>Rep. Pallone, Frank, Jr. [D-NJ-6]</fullName>
        <firstName>FRANK</firstName>
        <lastName>PALLONE</lastName>
        <party>D</party>
        <state>NJ</state>
        <district>6</district>
        <sponsorshipDate>2015-02-02</sponsorshipDate>
        <isOriginalCosponsor>True</isOriginalCosponsor>
      </item>
      <item>
        <bioguideId>G000410</bioguideId>
        <fullName>Rep. Green, Gene [D-TX-29]</fullName>
        <firstName>GENE</firstName>
        <lastName>GREEN</lastName>
        <party>D</party>
        <state>TX</state>
        <district>29</district>
        <sponsorshipDate>2015-02-02</sponsorshipDate>
        <isOriginalCosponsor>True</isOriginalCosponsor>
      </item>
      <item>
        <bioguideId>M001159</bioguideId>
        <fullName>Rep. McMorris Rodgers, Cathy [R-WA-5]</fullName>
        <firstName>Cathy</firstName>
        <lastName>McMorris Rodgers</lastName>
        <party>R</party>
        <state>WA</state>
        <district>5</district>
        <sponsorshipDate>2015-03-16</sponsorshipDate>
        <isOriginalCosponsor>False</isOriginalCosponsor>
      </item>
    </cosponsors>
    <cboCostEstimates>
      <item>
        <pubDate>2015-03-17T11:59:00Z</pubDate>
        <title>H.R. 639, Improving Regulatory Transparency for New Medical Therapies Act</title>
        <url>https://www.cbo.gov/publication/50039</url>
        <description>As ordered reported by the House Committee on Energy and Commerce on February 12,&amp;nbsp;2015</description>
      </item>
    </cboCostEstimates>
    <laws>
      <item>
        <type>Public Law</type>
        <number>114-89</number>
      </item>
    </laws>
    <policyArea>
      <name>Crime and Law Enforcement</name>
    </policyArea>
    <subjects>
      <legislativeSubjects>
        <item>
          <name>Administrative law and regulatory procedures</name>
        </item>
        <item>
          <name>Administrative remedies</name>
        </item>
        <item>
          <name>Department of Justice</name>
        </item>
        <item>
          <name>Drug safety, medical device, and laboratory regulation</name>
        </item>
        <item>
          <name>Drug trafficking and controlled substances</name>
        </item>
        <item>
          <name>Licensing and registrations</name>
        </item>
        <item>
          <name>Medical research</name>
        </item>
      </legislativeSubjects>
      <policyArea>
        <name>Crime and Law Enforcement</name>
      </policyArea>
    </subjects>
    <summaries>
      <summary>
        <versionCode>00</versionCode>
        <actionDate>2015-02-02</actionDate>
        <actionDesc>Introduced in House</actionDesc>
        <updateDate>2015-02-14T17:10:47Z</updateDate>
        <text><![CDATA[ <p><b>Improving Regulatory Transparency for New Medical Therapies Act</b></p>   <p>Amends the Controlled Substances Act to require any proceedings for the issuance, amendment, or repeal of a rule of the Attorney General for the classification of a controlled substance that are initiated at the request of the Secretary of Health and Human Services to control a drug or other substance not previously scheduled, where the Secretary has recommended the drug or other substance be placed in schedule II, III, IV, or V, to be commenced not later than 120 days after receipt of written recommendations from the Secretary. Requires the final rule to be issued not later than 60 days after the date on which both the public comment period has closed and the new drug is the subject of an approved new drug application, unless a hearing on the proposed rule is granted by the Attorney General.</p> <p>Directs the Attorney General, for the purposes of registration to manufacture a controlled substance in schedule III, IV, or V for use only in a clinical trial, to register an applicant, or serve upon the applicant an order to show cause why registration should not be denied, revoked, or suspended, not later than 180 days after receiving an application and all information necessary to make a determination about whether the issuance of such registration is inconsistent with the public interest.</p> <p>Directs the Attorney General, for the purposes of registration to manufacture a controlled substance in schedule I or II for use only in a clinical trial, to: (1) issue a notice of application not later than 90 days after receipt of an application and all necessary information to issue such notice; and (2) register an applicant, or serve upon the applicant an order to show cause why registration should not be denied, revoked, or suspended, within 180 days following the close of the comment period and receipt of all information necessary to make a determination about whether the issuance of such registration is consistent with the public interest and with U.S. obligations under international treaties in effect on May 1, 1971, unless a hearing on the application has been granted pursuant to a provision of the Controlled Substances Import and Export Act regarding emergency situations.</p> ]]></text>
      </summary>
      <summary>
        <versionCode>36</versionCode>
        <actionDate>2015-03-16</actionDate>
        <actionDesc>Passed House amended</actionDesc>
        <updateDate>2015-03-23T20:40:11Z</updateDate>
        <text><![CDATA[ <p><b>Improving Regulatory Transparency for New Medical Therapies Act</b></p> <p>(Sec. 2) This bill amends the Federal Food, Drug, and Cosmetic Act and the Public Health Service Act to delay the effective date of approval of a drug, biological product, or animal drug for which the Food and Drug Administration (FDA) recommends controls under the Controlled Substances Act until the Department of Justice (DOJ) issues a final interim rule for the drug. This delay also applies to conditional approval and indexing of animal drugs.</p> <p>This bill amends the Controlled Substances Act to require the DOJ to issue a final interim rule for a drug product recommended for controls by the FDA not later than 90 days after DOJ receives a recommendation for controls or the FDA approves the drug. The final interim rule is effective immediately.</p> <p>For purposes of submitting an application to extend a patent, a drug product recommended for controls is considered to be approved and have permission for commercial marketing and use on the date of FDA approval or the date an interim final rule is issued, whichever is later.</p> (Sec. 3) Timelines are established for DOJ to either register an applicant to manufacture a controlled substance for a clinical trial or serve an order to show cause upon the applicant.]]></text>
      </summary>
      <summary>
        <versionCode>35</versionCode>
        <actionDate>2015-10-26</actionDate>
        <actionDesc>Passed Senate amended</actionDesc>
        <updateDate>2016-01-15T18:05:40Z</updateDate>
        <text><![CDATA[ <p><b>Improving Regulatory Transparency for New Medical Therapies Act</b></p> <p>(Sec. 2) This bill amends the Federal Food, Drug, and Cosmetic Act and the Public Health Service Act to delay the effective date of approval of a drug, biological product, or animal drug for which the Food and Drug Administration (FDA) recommends controls under the Controlled Substances Act until the Department of Justice (DOJ) issues a final interim rule for the drug. This delay also applies to conditional approval and indexing of animal drugs.</p> <p>This bill amends the Controlled Substances Act to require the DOJ to issue a final interim rule for a drug product recommended for controls by the FDA not later than 90 days after DOJ receives a recommendation for controls or the FDA approves the drug. The final interim rule is effective immediately.</p> <p>For purposes of submitting an application to extend a patent, a drug product recommended for controls is considered to be approved and have permission for commercial marketing and use on the date of FDA approval or the date an interim final rule is issued, whichever is later.</p> <p>(Sec. 3) Timelines are established for DOJ to either register an applicant to manufacture a controlled substance for a clinical trial or serve an order to show cause upon the applicant.</p> <p>(Sec. 4) This bill amends the Controlled Substances Import and Export Act to allow exported controlled substances to be re-exported within the European Economic Area.</p>]]></text>
      </summary>
      <summary>
        <versionCode>49</versionCode>
        <actionDate>2015-11-25</actionDate>
        <actionDesc>Public Law</actionDesc>
        <updateDate>2016-01-21T17:52:06Z</updateDate>
        <text><![CDATA[ <p>(This measure has not been amended since it was passed by the Senate on October 26, 2015. The summary of that version is repeated here.)</p> <p><b>Improving Regulatory Transparency for New Medical Therapies Act</b></p> <p>(Sec. 2) This bill amends the Federal Food, Drug, and Cosmetic Act and the Public Health Service Act to delay the effective date of approval of a drug, biological product, or animal drug for which the Food and Drug Administration (FDA) recommends controls under the Controlled Substances Act until the Department of Justice (DOJ) issues a final interim rule for the drug. This delay also applies to conditional approval and indexing of animal drugs.</p> <p>This bill amends the Controlled Substances Act to require the DOJ to issue a final interim rule for a drug product recommended for controls by the FDA not later than 90 days after DOJ receives a recommendation for controls or the FDA approves the drug. The final interim rule is effective immediately.</p> <p>For purposes of submitting an application to extend a patent, a drug product recommended for controls is considered to be approved and have permission for commercial marketing and use on the date of FDA approval or the date an interim final rule is issued, whichever is later.</p> <p>(Sec. 3) Timelines are established for DOJ to either register an applicant to manufacture a controlled substance for a clinical trial or serve an order to show cause upon the applicant.</p> <p>(Sec. 4) This bill amends the Controlled Substances Import and Export Act to allow exported controlled substances to be re-exported within the European Economic Area.</p>]]></text>
      </summary>
    </summaries>
    <title>Improving Regulatory Transparency for New Medical Therapies Act</title>
    <titles>
      <item>
        <titleType>Display Title</titleType>
        <title>Improving Regulatory Transparency for New Medical Therapies Act</title>
      </item>
      <item>
        <titleType>Official Title as Introduced</titleType>
        <title>To amend the Controlled Substances Act with respect to drug scheduling recommendations by the Secretary of Health and Human Services, and with respect to registration of manufacturers and distributors seeking to conduct clinical testing.</title>
        <billTextVersionName>Introduced in House</billTextVersionName>
        <billTextVersionCode>IH</billTextVersionCode>
      </item>
      <item>
        <titleType>Short Titles as Introduced</titleType>
        <title>Improving Regulatory Transparency for New Medical Therapies Act</title>
      </item>
      <item>
        <titleType>Short Titles as Passed House</titleType>
        <title>Improving Regulatory Transparency for New Medical Therapies Act</title>
        <chamberCode>H</chamberCode>
        <chamberName>House</chamberName>
      </item>
      <item>
        <titleType>Short Titles as Passed Senate</titleType>
        <title>Improving Regulatory Transparency for New Medical Therapies Act</title>
        <chamberCode>S</chamberCode>
        <chamberName>Senate</chamberName>
      </item>
      <item>
        <titleType>Short Titles as Enacted</titleType>
        <title>Improving Regulatory Transparency for New Medical Therapies Act</title>
      </item>
    </titles>
    <amendments>
      <amendment>
        <number>2748</number>
        <congress>114</congress>
        <type>SAMDT</type>
        <purpose>In the nature of a substitute.</purpose>
        <updateDate>2020-12-15T19:04:15Z</updateDate>
        <latestAction>
          <actionDate>2015-10-26</actionDate>
          <text>Amendment SA 2748 agreed to in Senate by Unanimous Consent.</text>
          <links>
            <link>
              <name>SA 2748</name>
              <url>https://www.congress.gov/amendment/114th-congress/senate-amendment/2748</url>
            </link>
          </links>
        </latestAction>
        <sponsors>
          <item>
            <bioguideId>A000360</bioguideId>
            <fullName>Sen. Alexander, Lamar [R-TN]</fullName>
            <firstName>Lamar</firstName>
            <lastName>Alexander</lastName>
            <party>R</party>
            <state>TN</state>
          </item>
        </sponsors>
        <proposedDate>2015-10-26T04:00:00Z</proposedDate>
        <submittedDate>2015-10-26T04:00:00Z</submittedDate>
        <chamber>Senate</chamber>
        <amendedBill>
          <congress>114</congress>
          <type>HR</type>
          <originChamber>House</originChamber>
          <originChamberCode>H</originChamberCode>
          <number>639</number>
          <title>Improving Regulatory Transparency for New Medical Therapies Act</title>
          <updateDateIncludingText>2023-04-24T20:39:41Z</updateDateIncludingText>
        </amendedBill>
        <actions>
          <count>6</count>
          <actions>
            <item>
              <actionDate>2015-10-26</actionDate>
              <sourceSystem>
                <code>0</code>
                <name>Senate</name>
              </sourceSystem>
              <text>Amendment SA 2748 agreed to in Senate by Unanimous Consent.</text>
              <type>Floor</type>
            </item>
            <item>
              <actionDate>2015-10-26</actionDate>
              <sourceSystem>
                <code>0</code>
                <name>Senate</name>
              </sourceSystem>
              <text>Amendment SA 2748 proposed by Senator Portman for Senator Alexander. (consideration: CR S7495) In the nature of a substitute.</text>
              <type>Floor</type>
            </item>
            <item>
              <actionDate>2015-10-26</actionDate>
              <text>Senate amendment submitted</text>
              <type>Floor</type>
              <actionCode>91000</actionCode>
              <sourceSystem>
                <code>9</code>
                <name>Library of Congress</name>
              </sourceSystem>
            </item>
            <item>
              <actionDate>2015-10-26</actionDate>
              <text>Senate amendment proposed (on the floor): Amendment SA 2748 proposed by Senator Portman for Senator Alexander.(consideration: CR S7495)</text>
              <type>Floor</type>
              <actionCode>93000</actionCode>
              <sourceSystem>
                <code>9</code>
                <name>Library of Congress</name>
              </sourceSystem>
            </item>
            <item>
              <actionDate>2015-10-26</actionDate>
              <text>Senate amendment agreed to: Amendment SA 2748 agreed to in Senate by Unanimous Consent.</text>
              <type>Floor</type>
              <actionCode>94000</actionCode>
              <sourceSystem>
                <code>9</code>
                <name>Library of Congress</name>
              </sourceSystem>
            </item>
          </actions>
        </actions>
      </amendment>
    </amendments>
    <textVersions>
      <item>
        <type>Enrolled Bill</type>
        <date/>
        <formats>
          <item>
            <url>https://www.govinfo.gov/content/pkg/BILLS-114hr639enr/xml/BILLS-114hr639enr.xml</url>
          </item>
        </formats>
      </item>
      <item>
        <type>Engrossed Amendment Senate</type>
        <date>2015-10-26T04:00:00Z</date>
        <formats>
          <item>
            <url>https://www.govinfo.gov/content/pkg/BILLS-114hr639eas/xml/BILLS-114hr639eas.xml</url>
          </item>
        </formats>
      </item>
      <item>
        <type>Referred in Senate</type>
        <date>2015-03-17T04:00:00Z</date>
        <formats>
          <item>
            <url>https://www.govinfo.gov/content/pkg/BILLS-114hr639rfs/xml/BILLS-114hr639rfs.xml</url>
          </item>
        </formats>
      </item>
      <item>
        <type>Reported in House</type>
        <date>2015-03-16T04:00:00Z</date>
        <formats>
          <item>
            <url>https://www.govinfo.gov/content/pkg/BILLS-114hr639rh/xml/BILLS-114hr639rh.xml</url>
          </item>
        </formats>
      </item>
      <item>
        <type>Engrossed in House</type>
        <date>2015-03-16T04:00:00Z</date>
        <formats>
          <item>
            <url>https://www.govinfo.gov/content/pkg/BILLS-114hr639eh/xml/BILLS-114hr639eh.xml</url>
          </item>
        </formats>
      </item>
      <item>
        <type>Introduced in House</type>
        <date>2015-02-02T05:00:00Z</date>
        <formats>
          <item>
            <url>https://www.govinfo.gov/content/pkg/BILLS-114hr639ih/xml/BILLS-114hr639ih.xml</url>
          </item>
        </formats>
      </item>
      <item>
        <date>2015-11-26T04:59:59Z</date>
        <formats>
          <item>
            <url>https://www.govinfo.gov/content/pkg/PLAW-114publ89/uslm/PLAW-114publ89.xml</url>
          </item>
        </formats>
        <type>Public Law</type>
      </item>
    </textVersions>
    <latestAction>
      <actionDate>2015-11-25</actionDate>
      <text>Became Public Law No: 114-89.</text>
    </latestAction>
  </bill>
  <dublinCore xmlns:dc="http://purl.org/dc/elements/1.1/">
    <dc:format>text/xml</dc:format>
    <dc:language>EN</dc:language>
    <dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
    <dc:contributor>Congressional Research Service, Library of Congress</dc:contributor>
    <dc:description>This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.</dc:description>
  </dublinCore>
</billStatus>
